|Title:||Friedman Distinguished Professor of Neurology|
|Affiliation:||Washington University School of Medicine|
|Street Address 1:||4488 Forest Park Ave, Suite 160|
Member reports the following financial or other potential conflicts of interest: [Last Modified: 9 May 2005]
Neither Dr. Morris nor his family owns stock or has equity interest (outside of mutual funds or other externally directed accounts) in any pharmaceutical or biotechnology company. From July 2002 to July 2003, Dr. Morris participated in clinical trials of antidementia drugs sponsored by Elan, Eli Lilly, and Merck. He has also served as a consultant or received speaking honoraria for the following companies: Celera, Forest Labs, Janssen, Neurochem, Novartis, and OCC/Johnson & Johnson.